Literature DB >> 2847408

Carboxyl-terminal region of Sendai virus P protein is required for binding to viral nucleocapsids.

K W Ryan1, D W Kingsbury.   

Abstract

The Sendai virus P protein is a component of the viral nucleocapsid, where it participates in RNA synthesis. To identify domains of the protein involved in nucleocapsid recognition, deleted P protein molecules were generated from a cDNA clone of its gene. In vitro transcription of the complete gene and translation of the transcript generated a protein with electrophoretic mobility and immunoreactivity indistinguishable from those of authentic P protein. The in vitro product bound specifically to nucleocapsids when mixed with extracts from infected cells. However, a product lacking only 30 carboxyl-terminal amino acid residues (5% of the molecule) did not bind. Residues within a 195 amino acid region, adjacent to and overlapping by one amino acid with the carboxyl-terminal 30 residues, were also required for binding. No other protein region was required. Therefore, the 224-residue region which includes the carboxyl terminus appears to contain the nucleocapsid attachment site, and the 30 terminal residues either form part of the site or are required to maintain an active conformation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2847408     DOI: 10.1016/0042-6822(88)90059-1

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  15 in total

1.  Dissection of individual functions of the Sendai virus phosphoprotein in transcription.

Authors:  M C Bowman; S Smallwood; S A Moyer
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

2.  The C-terminal 88 amino acids of the Sendai virus P protein have multiple functions separable by mutation.

Authors:  Jeffery Tuckis; Sherin Smallwood; Joyce A Feller; Sue A Moyer
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

3.  Complexes of Sendai virus NP-P and P-L proteins are required for defective interfering particle genome replication in vitro.

Authors:  S M Horikami; J Curran; D Kolakofsky; S A Moyer
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

4.  Oligomerization of Mumps Virus Phosphoprotein.

Authors:  Adrian Pickar; Andrew Elson; Yang Yang; Pei Xu; Ming Luo; Biao He
Journal:  J Virol       Date:  2015-08-26       Impact factor: 5.103

5.  Sendai virus protein-protein interactions studied by a protein-blotting protein-overlay technique: mapping of domains on NP protein required for binding to P protein.

Authors:  H E Homann; W Willenbrink; C J Buchholz; W J Neubert
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

6.  Association of the Sendai virus C protein with nucleocapsids.

Authors:  H Yamada; S Hayata; T Omata-Yamada; H Taira; K Mizumoto; K Iwasaki
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

7.  Identification of protein regions involved in the interaction of human respiratory syncytial virus phosphoprotein and nucleoprotein: significance for nucleocapsid assembly and formation of cytoplasmic inclusions.

Authors:  B García-Barreno; T Delgado; J A Melero
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

8.  The matrix proteins of neurovirulent subacute sclerosing panencephalitis virus and its acute measles virus progenitor are functionally different.

Authors:  A Hirano; A H Wang; A F Gombart; T C Wong
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

9.  Interaction of the C-terminal domains of sendai virus N and P proteins: comparison of polymerase-nucleocapsid interactions within the paramyxovirus family.

Authors:  Klaartje Houben; Dominique Marion; Nicolas Tarbouriech; Rob W H Ruigrok; Laurence Blanchard
Journal:  J Virol       Date:  2007-04-25       Impact factor: 5.103

10.  Characterization of nucleocapsid binding by the measles virus and mumps virus phosphoproteins.

Authors:  Richard L Kingston; Walter A Baase; Leslie S Gay
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.